The estimated Net Worth of Leroy E. Md Ph D Hood is at least $406 Thousand dollars as of 12 February 2021. Leroy Hood owns over 5,000 units of Omeros stock worth over $273,755 and over the last 15 years he sold OMER stock worth over $0. In addition, he makes $132,670 as Independent Director at Omeros.
Leroy has made over 4 trades of the Omeros stock since 2010, according to the Form 4 filled with the SEC. Most recently he exercised 5,000 units of OMER stock worth $22,650 on 12 February 2021.
The largest trade he's ever made was exercising 25,510 units of Omeros stock on 1 July 2010 worth over $20,408. On average, Leroy trades about 2,069 units every 176 days since 2009. As of 12 February 2021 he still owns at least 74,390 units of Omeros stock.
You can see the complete history of Leroy Hood stock trades at the bottom of the page.
Dr. Leroy E. Hood M.D. Ph.D. serves as Independent Director of the Company. He has served on our board of directors since March 2001. He also has served on our nominating and governance committee since September 2009, on our compensation committee since July 2011 and on our scientific committee since September 2019. Dr. Hood previously served as a member of our audit committee from September 2009 to December 2009 and from June 2012 to September 2012. Dr. Hood has served as senior vice president and chief science officer of Providence Health & Services, a multi-state, not-for-profit health system, since April 2016, and is the chief strategy officer of the Institute for Systems Biology, a non-profit research institute dedicated to the study and application of systems biology. Dr. Hood co-founded the Institute for Systems Biology in 2000 and served as its president through December 2017. Previously, Dr. Hood was founder and chairman of the Department of Molecular Biotechnology at the University of Washington School of Medicine. Dr. Hood also co-founded Amgen, Inc., Applied Biosystems, Inc., Darwin Molecular Technologies, Inc., Rosetta Inpharmatics, Inc. and SyStemix, Inc. Dr. Hood is a member of the National Academy of Sciences, the American Philosophical Society, the American Association of Arts and Sciences, the Institute of Medicine and the National Academy of Engineering. Dr. Hood received his Ph.D. and B.S. from the California Institute of Technology and his M.D. from The Johns Hopkins School of Medicine. Our nominating and governance committee has concluded that Dr. Hood should continue to serve on the board of directors based on his scientific expertise in drug discovery and development and experience in founding and building biotechnology and pharmaceutical companies.
As the Independent Director of Omeros, the total compensation of Leroy Hood at Omeros is $132,670. There are 11 executives at Omeros getting paid more, with Gregory Demopulos having the highest compensation of $4,825,130.
Leroy Hood is 81, he's been the Independent Director of Omeros since 2001. There are 1 older and 29 younger executives at Omeros. The oldest executive at Omeros Corporation is Ray Aspiri, 83, who is the Independent Director.
Leroy's mailing address filed with the SEC is 201 ELLIOTT AVENUE WEST, , SEATTLE, WA, 98119.
Over the last 15 years, insiders at Omeros have traded over $719,810 worth of Omeros stock and bought 141,095 units worth $829,835 . The most active insiders traders include Gregory A Md Demopulos, Marcia S. Kelbon, and Daniel K Spiegelman. On average, Omeros executives and independent directors trade stock every 53 days with the average trade being worth of $97,792. The most recent stock trade was executed by Gregory A Md Demopulos on 17 November 2023, trading 15,000 units of OMER stock currently worth $25,200.
omeros is a seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.
Omeros executives and other stock owners filed with the SEC include: